Related references
Note: Only part of the references are listed.Phenome-Wide Association Studies Uncover a Novel Association of Increased Atrial Fibrillation in Male Patients With Systemic Lupus Erythematosus
April Barnado et al.
ARTHRITIS CARE & RESEARCH (2018)
Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease
Hanan Al Rayes et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients
Tarun S. Sharma et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential
Rebecca A. Capel et al.
HEART RHYTHM (2015)
Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus
Ricardo Alkmim Teixeira et al.
EUROPACE (2014)
Cardiac Manifestations of Systemic Lupus Erythematosus
Jonathan J. Miner et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Chloroquine Terminates Stretch-Induced Atrial Fibrillation More Effectively Than Flecainide in the Sheep Heart
David Filgueiras-Rama et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)
Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine
Sami F. Noujaim et al.
CARDIOVASCULAR RESEARCH (2011)
Anti-Ro/SSA-Associated Corrected QT Interval Prolongation in Adults: The Role of Antibody Level and Specificity
Pietro Enea Lazzerini et al.
ARTHRITIS CARE & RESEARCH (2011)
Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody-Positive Patients
Michelle Petri
CURRENT RHEUMATOLOGY REPORTS (2011)
The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus
Hyejung Jung et al.
ARTHRITIS AND RHEUMATISM (2010)
Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
CY Chen et al.
CLINICAL TOXICOLOGY (2006)
Share Paper
